1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(6-hydroxyquinolin-2-yl)ethane-1,2-dione

ID: ALA4533029

PubChem CID: 5280292

Max Phase: Preclinical

Molecular Formula: C23H21N3O4

Molecular Weight: 403.44

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC1CN(C(=O)c2ccccc2)CCN1C(=O)C(=O)c1ccc2cc(O)ccc2n1

Standard InChI:  InChI=1S/C23H21N3O4/c1-15-14-25(22(29)16-5-3-2-4-6-16)11-12-26(15)23(30)21(28)20-9-7-17-13-18(27)8-10-19(17)24-20/h2-10,13,15,27H,11-12,14H2,1H3

Standard InChI Key:  SJJRAIDETBSBKL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   30.1577   -2.3525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1577   -3.1697    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8629   -3.5742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5682   -3.1697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5682   -2.3525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8629   -1.9398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2771   -1.9460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9836   -2.3567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9797   -3.1749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6853   -3.5855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3952   -3.1789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3950   -2.3575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6887   -1.9506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2795   -1.1288    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.4505   -3.5793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7422   -3.1718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4517   -4.3965    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.7411   -2.3546    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.0351   -3.5814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3294   -3.1734    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3368   -4.8078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0405   -4.3965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6235   -4.4004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6233   -3.5841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9174   -3.1779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2111   -3.5869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2153   -4.4063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9218   -4.8088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8629   -4.3914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5098   -4.8187    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  2  0
  2 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  2  0
 16 19  1  0
 19 20  2  0
 20 24  1  0
 23 21  1  0
 21 22  2  0
 22 19  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 23  2  0
  3 29  1  0
 27 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4533029

   Piperazine, 4-benzoyl-1-[1,2-dioxo-2-(6-hydroxy-2-quinolinyl)ethyl]-2-methyl-

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 403.44

Molecular Weight (Monoisotopic): 403.1532

AlogP: 2.50

#Rotatable Bonds: 3

Polar Surface Area: 90.81

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.16

CX Basic pKa: 1.25

CX LogP: 2.72

CX LogD: 2.71

Aromatic Rings: 3

Heavy Atoms: 30

QED Weighted: 0.54

Np Likeness Score: -0.92

References

1. Wang T, Wallace OB, Zhang Z, Fang H, Yang Z, Robinson BA, Spicer TP, Gong YF, Blair WS, Shi PY, Lin PF, Deshpande M, Meanwell NA, Kadow JF..  (2019)  A survey of core replacements in indole-based HIV-1 attachment inhibitors.,  29  (11): [PMID:30940396] [10.1016/j.bmcl.2019.03.018]

Source

Source(1):

• Scientific Literature